A new study published in Human Reproduction looked at patient attitudes to IVF treatment add-ons.
The authors – including Sarah Norcross, director of PET (the Progress Educational Trust) – convened focus groups of women with prior experience of fertility treatment to answer the question: 'What factors are important for patients when evaluating the efficacy, safety, cost, and acceptability of IVF add-ons?'
The most important factor for the majority of participants was the chance of achieving a live birth, but an impact on interim steps – such as the number of eggs collected or embryos created – was also seen as valuable.
In terms of cost, the participants talked about needing to balance the cost of add-ons with saving for future cycles, as well as the possibility of regret if they didn't try something.
Read the full study here.